Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2025-12-24 @ 11:19 PM
NCT ID:
NCT03152656
Eligibility Criteria:
Inclusion Criteria:
* Taiwan FH Diagnostic Criteria was revised from Dutch Lipid Clinic Network (DLCN) Criteria with consensus of experts in cardiology, genetic, and metabolism specialty, and published by Taiwan Society of Lipids \& Atherosclerosis in 2014.
Exclusion Criteria:
* The main exclusion criteria will be secondary causes of hyperlipidemia other than FH (i.e. untreated hypothyroidism, nephrotic syndrome), hemodynamically significant valvular or congenital heart disease, life-threatening malignancy, treatment with immunosuppressive agents, or any condition or situation which, in the opinion of the investigator, might be not suitable for this registration.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03152656
Study Brief:
Protocol Section:
NCT03152656